Article Versions Notes

Stana M, Grambozov B, Gaisberger C, Karner J, Ruznic E, Berchtold J, Zellinger B, Moosbrugger R, Studnicka M, Fastner G, et al. Carbon Monoxide Diffusing Capacity (DL_CO) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage III. Diagnostics. 2022; 12(5):1027. https://doi.org/10.3390/diagnostics12051027

Stana, Markus, Brane Grambozov, Christoph Gaisberger, Josef Karner, Elvis Ruznic, Johannes Berchtold, Barbara Zellinger, Raphaela Moosbrugger, Michael Studnicka, Gerd Fastner, and et al. 2022. "Carbon Monoxide Diffusing Capacity (DL_CO) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage III" Diagnostics 12, no. 5: 1027. https://doi.org/10.3390/diagnostics12051027

Stana, M., Grambozov, B., Gaisberger, C., Karner, J., Ruznic, E., Berchtold, J., Zellinger, B., Moosbrugger, R., Studnicka, M., Fastner, G., Sedlmayer, F., & Zehentmayr, F. (2022). Carbon Monoxide Diffusing Capacity (DL_CO) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage III. Diagnostics, 12(5), 1027. https://doi.org/10.3390/diagnostics12051027